Redecol is a medical device company focussed on the development of an asthma monitoring device to address the need for a new type of lung function test which exists within the monitoring sector of asthma management.

 

Redecol is using patented sensor technology to develop a unique asthma monitoring tool which does not require a forced breathing technique.

At Redecol we are dedicated to helping patients throughout the world who have respiratory disorders such as asthma and COPD to improve their health through providing easy-to-use home-monitoring solutions. Our team are committed to bring solutions that improve the outcomes for all patients, whilst being cost-effective for healthcare systems from the very start.

Redecol employs a core team with a wealth of experience in the medical device industry. This team is supported by a strong network of consultants and agencies to provide the highest possible quality of skills and knowledge required to develop a world class medical device.

 
 

Board of Directors

 
About us template.png

Graham Hine
Chairman of the Board

Graham has a broad experience of Chairman and CEO roles across a range of medical equipment, nanotechnology and sensor companies, including listed and VC backed entities.

Andy Moss
Managing Director

Andy has considerable pharmaceutical and medical device industry experience, particularly with regard to market development & market access. Andy has devised and led several high value projects, notably the HER2 testing project in collaboration with the NHS Cancer Action team making HER2 testing available to all patients across the UK. At Boston Scientific, Andy built and led an EMEA team delivering significant innovation in severe asthma.

Zia.jpg

Zia Mursaleen
Finance Director

Zia is a chartered accountant and corporate financier having qualified and worked with Deloitte for 10 years. He is a founder of VA Corporate Finance Ltd providing corporate finance and financial consultancy to SMEs for over 20 years.

 
Barbara Lead  Non-Exec Director  With a wealth of experience in the asthma space, Barbara is the CEO of Oval Medical, which was recently acquired by SMC, becoming the first successful exit for Syndicate Room.

Tim Coutts
Non-Exec Director

Tim brings over 20 years’ experience in the medtech industry from multinational companies, such as Boston Scientific to SME’s and is a former board menber of the ABHI

About us template.png

Barbara Lead
Non-Exec Director

With a wealth of experience in the asthma space, Barbara is the CEO of Oval Medical, which was recently acquired by SMC, becoming the first successful exit for Syndicate Room.

 
 

The Redecol Team

 
About+us+template.jpg

Andy Moss
Managing Director

Andy has considerable pharmaceutical and medical device experience, particularly with regard to market development, market access and in building specialist Sales & Marketing teams to deliver these strategies.

Zia.jpg

Zia Mursaleen
Finance Director

Zia is a chartered accountant and corporate financier having qualified and worked with Deloitte for 10 years. He is a founder of VA Corporate Finance Ltd providing corporate finance and financial consultancy to SMEs for over 20 years.

 
Lee-01.jpg

Lee Brooks
R&D Manager

Previously employed at Anaxsys, Lee has developed the sensor technology at the heart of the Breathe Easy Flow Device. Following completion of his PhD, he has been instrumental in developing the production and testing of sensors for clinical and commercial use.

About us template.png

Margaret McQueen
QA Manager

Margaret joined Redecol from Sanofi with nearly 20' years' experience in the research and development of asthma products. Her clincal manufacturing experience supports the regulatory and quality system for Redecol.